PATENT CLAIM ANALYSIS

Application Number: 15900533
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "034000"]

Abstract:
The present invention relates to compounds and compositions and their applications as pharmaceuticals for treating, preventing, or reversing injury to skeletal or cardiac muscles, for treating or preventing diseases relating to the structure and function of skeletal or cardiac muscle, and for inducing regeneration or restructuring of skeletal or cardiac muscle as a means of treating diseases relating to abnormalities in skeletal or cardiac muscle structure and function in a human or animal subject. Further aspects relate to the same or similar applications for bone and bone diseases.

Claim (Index 12):
The method of  claim 5  wherein the (+)-epicatechin and/or (\u2212)-epicatechin or an epicatechin derivative is administered orally or intravenously or intramuscularly, at 5 mg to 2 grams per day, in a single dose or in divided doses.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 2.04348
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14387117', '10858353', '13489317', '14762373', '12992501']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7527707656097452
- 35 USC 102 Novelty (BERT): 0.6051937865151228
- Combined Prediction Score: 0.738013067700283
- Mean Citation Score: 263.090616
- Max Citation Score: 528.89923
- Similarity Product: 485.8073440951432

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test